Speaker illustration

Mr Fawaz Alenazy

Birmingham ()

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Young Investigator Awards Session in Thrombosis

Thumbnail

This platform is supported by

logo Novo Nordisk